Dr. Martens PLC

Report Publication Announcement • Jun 13, 2023

/*<![CDATA[*/ /**/ /**/ /**/ p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .p{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.p{}p.ac{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:center;line-height:150%}span.aa{font-size:10.0pt;line-height:150%;font-family:Interstate}p.ad{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height:150%}span.y{font-size: 10.0pt;line-height:150%;font-family:Interstate}p.ae{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-indent:-18.0pt;line-height:150%}span.w{font-size:10.0pt;line-height:150%;font-family:Symbol}p.af{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-indent:-18.0pt;line-height: 150%}span.u{font-size:10.0pt;line-height:150%;font-family: Symbol} span.t{font-size:10.0pt;line-height: 150%;font-family:Interstate}p.ag{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:36.0pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-indent:-18.0pt;line-height:150%}span.m{}p.ah{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt; margin-left:0cm;line-height:150%;background:white}span.ai{font-size:10.0pt;line-height:150%;font-family:Interstate}span.q{font-size:10.0pt;line-height:150%;font-family:Interstate;font-weight: normal} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .p{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/ National Storage Mechanism | Additional information

RNS Number : 4483C

Dr. Martens PLC

13 June 2023

Dr. Martens plc (the "Company")

2023 Annual Report and Notice of Annual General Meeting

Further to the announcement of its preliminary results for the financial year ended 31 March 2023 and in accordance with Listing Rule 9.6.1, the Company announces that the following documents have been submitted in full unedited text to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

• Annual Report and Accounts for the financial year ended 31 March 2023 (the "2023 Annual Report")
• Notice of the 2023 Annual General Meeting (the "2023 Notice of Meeting"), which will take place at 9.30am on Thursday 13 July 2023 at Holiday Inn London - Camden Lock, 30 Jamestown Road, Camden, London, NW1 7BY
• Proxy for the 2023 Annual General Meeting

In compliance with rule 6.3.5R of the Disclosure Guidance and Transparency Rules, the 2023 Annual Report and 2023 Notice of Meeting are also available on the Company's website, www.drmartensplc.com.

For further information, please contact:

Paul Rolling, Assistant Company Secretary

+447584243562

Bethany Barnes, Director of Investor Relations

+447825187465

ENDS

**

About Dr. Martens**

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSGPUPPQUPWGAP